Top Markets
Coin of the day
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
Classement en actions #15973
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Prix de l'action
$15.42
Capitalisation boursière
$320.83M
Changement (1 jour)
-1.52%
Changement (1 an)
40.67%
Pays
IT
Échange Newron Pharmaceuticals S.p.A. (NP5)

Catégorie

Historique du prix de l'action pour Newron Pharmaceuticals S.p.A. (NP5)
Prix de clôture le plus élevé : $15.42 le 2026-09-01

Prix de clôture le plus bas : $6.42 le 2019-07-01
Historique du prix de l'action de Newron Pharmaceuticals S.p.A. de 2019 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -24.46%
2025 190.90%
2024 71.92%
2023 246.71%
2022 -14.11%
2021 -28.37%
2020 -64.91%
2019 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.27 40.22%
US
$1.02K 43.73%
NL
$152.77 534.16%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH